| # | Drug | Count |
|---|---|---|
| 0 | ADALIMUMAB | 96 |
| 1 | PREDNISONE | 20 |
| 2 | METHOTREXATE SODIUM | 17 |
| 3 | METHOTREXATE | 16 |
| 4 | VEDOLIZUMAB | 16 |
| 5 | ERGOCALCIFEROL | 14 |
| 6 | AZATHIOPRINE | 12 |
| 7 | INFLIXIMAB | 12 |
| 8 | MESALAMINE | 11 |
| 9 | ACETAMINOPHEN | 10 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | QUAZEPAM | 1 | 0.0033 |
| 1 | ISOFLURANE | 6 | 0.0031 |
| 2 | SOYBEAN OIL | 1 | 0.0015 |
| 3 | SULINDAC | 2 | 0.0008 |
| 4 | KETAMINE HYDROCHLORIDE | 4 | 0.0008 |
| 5 | PSYLLIUM HUSK | 1 | 0.0007 |
| 6 | ZOLBETUXIMAB | 1 | 0.0007 |
| 7 | ERGOCALCIFEROL | 14 | 0.0005 |
| 8 | SODIUM SULFATE, POTASSIUM SULFATE, MAGNESIUM SULFATE | 2 | 0.0005 |
| 9 | ETEPLIRSEN | 1 | 0.0004 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 34 |
| 1 | Integrin Receptor Antagonist [EPC] | 21 |
| 2 | Tumor Necrosis Factor Blocker [EPC] | 20 |
| 3 | Folate Analog Metabolic Inhibitor [EPC] | 16 |
| 4 | Nonsteroidal Anti-inflammatory Drug [EPC] | 16 |
| 5 | Benzodiazepine [EPC] | 15 |
| 6 | Provitamin D2 Compound [EPC] | 14 |
| 7 | Proton Pump Inhibitor [EPC] | 13 |
| 8 | Purine Antimetabolite [EPC] | 13 |
| 9 | Vitamin C [EPC] | 13 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Claudin 18.2-directed Cytolytic Antibody [EPC] | 1 | 0.0007 |
| 1 | Provitamin D2 Compound [EPC] | 14 | 0.0005 |
| 2 | Lipid Emulsion [EPC] | 1 | 0.0004 |
| 3 | Integrin Receptor Antagonist [EPC] | 21 | 0.0002 |
| 4 | Human Immunoglobulin G [EPC] | 4 | 0.0002 |
| 5 | Antisense Oligonucleotide [EPC] | 2 | 0.0002 |
| 6 | Vascular Endothelial Growth Factor Receptor 2 Antagonist [EPC] | 1 | 0.0002 |
| 7 | Vitamin D2 Analog [EPC] | 1 | 0.0001 |
| 8 | General Anesthetic [EPC] | 6 | 0.0001 |
| 9 | Purine Antimetabolite [EPC] | 13 | 0.0001 |